Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to AdolescentsDaniel González, Michael Cohen‐Wolkowiez, Chiara Melloni et al.|Clinical Pharmacology & Therapeutics|2014Cited by 70
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and ChildrenJulie Autmizguine, Daniel González, Chiara Melloni et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 29
Vancomycin Cerebrospinal Fluid Pharmacokinetics in Children with Cerebral Ventricular Shunt InfectionsJulie Autmizguine, Kevin Watt, Cassie Moran et al.|The Pediatric Infectious Disease Journal|2014Cited by 9
External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and SulfamethoxazoleYi Shuan Shirley Wu, Daniel González, Michael Cohen‐Wolkowiez et al.|Antimicrobial Agents and Chemotherapy|2021Cited by 5
Pharmacokinetics of Dexamethasone in Children and Adolescents with ObesityJiali Wen, Daniel González, Sean McCann et al.|The Journal of Clinical Pharmacology|2024Cited by 4